Logo

Thermo Fisher Scientific Ion Torrent Oncomine Myeloid MRD Assay

Aug 04, 2022

Thermo Fisher Scientific has launched the Ion Torrent Oncomine Myeloid MRD Assay, a next-generation sequencing (NGS)-based test for research in myeloid measurable residual disease (MRD) from ​blood and bone marrow samples. According to Thermo Fisher, the assay enables sensitive variant detection as low as 0.05 percent allele frequency for key DNA mutations in 33 genes and evaluation of more than 900 isoforms in 43 RNA fusion driver genes. The end-to-end workflow can deliver results in as little as two days with an integrated informatics pipeline and reporting tool that can help to minimize user hands-on time, the company said.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.